Galera, headquartered in Malvern, Pa., is a clinical-stage biotechnology company focused on the development of drugs targeting oxygen metabolic pathways....more
Comvest Investment Partners V closed with $893 million in total capital commitments, above the $700 million target established at the outset of fundraising....more
Intellia, based in Cambridge, Mass., is gene editing company focused on the development of curative medicines utilizing a developed biological tool known as the CRISPR/Cas9 system....more
Syndax, based in Waltham, Mass., is a clinical stage biopharmaceutical company. It is developing entinostat, an investigational, targeted, epigenetic immunomodulator, as a combination therapy in multiple cancer indications...more
Metacrine, based in San Diego, Calif., is a biotechnology company focused on advancing research in nuclear hormone receptors for treatment of metabolic diseases originated at the Salk Institute for Biological Studies....more
Rapid Micro Biosystems, based in Lowell, Mass., develops imaging technology that detects microbial contamination in the manufacture of pharmaceutical, biotechnology and other products....more
OrthoSensor has announced it has raised $19 million in a private placement of series C preferred stock.
OrthoSensor, based in Dania Beach, FL, is a developer of intelligent orthopedic devices and data services....more
Cardiac Dimensions, based in Kirkland, Wash., develops minimally invasive treatment modalities to address heart failure and related cardiovascular conditions....more
CardioDx, headquartered in Redwood City, Calif., is a molecular diagnostics company specializing in cardiovascular genomics.
Participants in this round of financing included Alberta Investment Management Corp. and the...more